WEALTHHOUND.COM, INC.Warrant Modification Agreement • November 16th, 2000 • Wealthhound Com Inc • Services-business services, nec
EX-10.1 2 dex101.htm FORM OF WARRANT MODIFICATION AGREEMENT FORM OF WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • May 5th, 2020 • Georgia
This WARRANT MODIFICATION AGREEMENT (the “Agreement”), dated as of November 14, 2005 (the “Effective Date”), is made pursuant to the terms of the Warrant Agreement and Form of Warrant, dated as of , 200 , (as supplemented or amended to the date of this Agreement, the “Warrant Agreement”), and is entered into by and between Flag Financial Corporation, a Georgia corporation (“Company”), and (the “Holder”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • May 12th, 2016 • Neothetics, Inc. • Pharmaceutical preparations
This Warrant Modification Agreement is entered into as of March 30, 2016, between Hercules Technology III, L.P. (the “Warrantholder”) and Neothetics, Inc. (formerly known as Lithera, Inc., the “Company”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • January 4th, 2022 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Warrant Modification Agreement (this “Agreement”), effective as of December 1, 2021, is made pursuant to the terms of that certain Common Stock Purchase Warrant (“Warrant” or “Warrant Agreement”, attached as Form of Warrant) dated October 5, 2020, by and between Nuo Therapeutics Inc., a Delaware corporation, (the “Company”) and the undersigned holder(s) (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.001 per shares (the “Common Stock”), issued by the Company, as set forth on Schedule A (collectively, the “Warrants”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • November 3rd, 2015 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
This Warrant Modification Agreement is entered into as of September 17 2015, between Hercules Technology Growth Capital, Inc. (the “Warrantholder”) and AcelRx Pharmaceuticals, Inc. (the “Company”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • April 14th, 2004 • Ramp Corp • Services-computer programming, data processing, etc. • New York
THIS WARRANT MODIFICATION AGREEMENT (this “Agreement”), dated as of April 21, 2003, by and between Medix Resources, Inc., a Colorado corporation (the “Company”), and the warrant holder identified on the signature page hereto (the “Warrant Holder”).
RECITALS:Warrant Modification Agreement • March 31st, 1997 • Corrections Corporation of America • Services-facilities support management services • Delaware
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • March 13th, 2019 • Arsanis, Inc. • Biological products, (no disgnostic substances)
This Warrant Modification Agreement is entered into as of December 11, 2018 between Hercules Capital, Inc. (the “Warrantholder”) and X4 Pharmaceuticals, Inc. (the “Company”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • November 2nd, 2016 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
This Warrant Modification Agreement is entered into as of September 30, 2016, between Hercules Capital, Inc., formerly known as Hercules Technology Growth Capital, Inc. (the “Warrantholder”) and AcelRx Pharmaceuticals, Inc. (the “Company”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • November 3rd, 2015 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
This Warrant Modification Agreement is entered into as of September 17 2015, between Hercules Technology II, L.P. (the “Warrantholder”) and AcelRx Pharmaceuticals, Inc. (the “Company”).
WARRANT MODIFICATION AGREEMENTWarrant Modification Agreement • November 2nd, 2016 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
This Warrant Modification Agreement is entered into as of September 30, 2016, between Hercules Technology II, L.P. (the “Warrantholder”) and AcelRx Pharmaceuticals, Inc. (the “Company”).
